Latest News on Clinical Trials

GSK begins clinical trials of pancreatic cancer combination

GlaxoSmithKline plans to carry out clinical trials on its pancreatic drug hopeful, GSK547, following promising results when treating mice and laboratory-grown tumour cells. The experimental drug was found to be effective when paired with Merck & Co’s checkpoint...

read more

Digital Clinical Trials: A framework for success

Excerpted from PMLive.com, There is increasing interest in digital trials, that is the use of mHealth and mobile technology to capture insights outside the traditional clinical setting. The drivers are clear – spiralling costs, questions with respect to existing...

read more

Examining the Technology for Clinical Trials

Mike Novotny for EPM Magazine writes (excerpt) "Among the greatest factors behind the recruitment and retention struggles the industry faces are a wariness of unproven treatments (often referred to as the ‘guinea pig fear’) and the fact that, for many potential...

read more

RegeneRx Partner Updates on Clinical Trials

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced a clinical trial update provided by GtreeBNT, RegeneRx's partner...

read more

The Importance of Diversity in Clinical Trials

Chelsea Weidman Burke for Biospace writes (excerpted) The lack of diversity (regarding clinical trials)  isn’t limited to African Americans – most clinical trials lacked participation from other minorities too. Although Asians are well represented in some...

read more
SEARCH FOR STUDIES